Diabetic Men At 13 Times Higher Risk For End-Stage Renal Disease Than Non-Diabetic Men

December 17, 1997

Diabetes has long been known to be one major cause of end-stage renal disease (ESRD), but the magnitude of risk has been uncertain. Now, a study led by Johns Hopkins researchers finds that diabetic men are nearly 13 times more likely to develop ESRD than non-diabetic men.

Results of the study, published in the Dec. 17 issue of the Journal of the American Medical Association, also show that diabetic men are four times as likely as their non-diabetic counterparts to develop ESRD attributed to such non-diabetic disorders as high blood pressure or kidney infection.

ESRD is the most advanced form of kidney failure, occurring when both kidneys gradually cease to function. Patients with ESRD require kidney dialysis or kidney transplants to survive.

"These data demonstrate that improvements in the prevention and control of diabetes, even for those with milder cases, could substantially reduce the health burden imposed by chronic renal failure," says Frederick L. Brancati, M.D., M.H.S., lead author of the study and an assistant professor of internal medicine and epidemiology at Hopkins.

The study, the first to show the relative risk of diabetics' developing ESRD, was supported by the National Institutes of Health. It was done in collaboration with researchers from the University of Minnesota in Minneapolis, and Northwestern University Medical School in Chicago.

Researchers studied the records of 332,544 men ages 35 to 57 who participated in the Multiple Risk Factor Intervention Trial (MRFIT), a national, multicenter trial conducted in the 1970s that aimed to reduce death rates from coronary artery disease by helping the men control high blood pressure, lower cholesterol and quit smoking.

ESRD risk was calculated by comparing these records with the names of men enrolled in the national Health Care Financing Administration's ESRD treatment registry between 1973 and 1990. Death from renal disease was assessed using data from the National Death Index and the Social Security Administration.

Over an average follow-up of 16 years, there were 136 cases of ESRD in 5,147 diabetic men and 678 cases in 327,397 non-diabetic men. Age-adjusted incidence of all-cause ESRD in the diabetic men was 199.8 per 100,000 person-years compared with 13.7 per 100,000 person-years in their non-diabetic counterparts. Diabetic men also were at higher risk for ESRD ascribed to causes other than diabetes.

The study's other authors were Paul K. Whelton, M.D., M.Sc., and Michael J. Klag, M.D., M.P.H., of Hopkins; Bryan L. Randall, M.S., and James D. Neaton, Ph.D., of the University of Minnesota; and Jeremiah Stamler, M.D., of Northwestern.

--JHMI--





Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkin@welchlink.welch.jhu.edu or 76520.560@compuserve.com.

On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu, Quadnet at http://www.quad-net.com, ScienceDaily at http://www.sciencedaily.com or on CompuServe in the SciNews-MedNews library of the Journalism Forum under file extension ".JHM".

Johns Hopkins Medicine

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.